Kestine 10 (Ebastine)

Ebastine selectively blocks peripheral H1 receptors on mast cells and basophils, preventing histamine from binding and initiating the cascade that leads to vasodilation, increased vascular permeability and sensory nerve stimulation. Because it does not readily cross the blood‑brain barrier, it produces minimal sedation compared with first‑generation antihistamines.

The prescribed dose of ebastine is determined by the treating physician based on the patient’s age, condition severity and concomitant therapies. Typical adult dosing ranges from 10 mg once daily, but exact instructions must be obtained from a qualified healthcare professional.

Safety data for ebastine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by a healthcare provider after evaluating the individual situation.

To place an order, submit an enquiry on the Kestine 10 product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with first‑generation antihistamines, ebastine offers similar efficacy for allergic symptoms but with a lower risk of sedation and anticholinergic effects because of its peripheral selectivity and limited central nervous system penetration. It is comparable to other second‑generation agents such as cetirizine or loratadine, with a favorable safety profile.

Store Kestine 10 at ambient temperature, preferably below 25 °C, in the original packaging. Protect the tablets from moisture, excessive heat and direct sunlight to maintain potency throughout the shelf life.

Kestine 10 is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the specific instructions provided by their prescriber to ensure optimal absorption and effect.

Although rare, serious adverse reactions may include anaphylaxis, severe skin reactions such as Stevens‑Johnson syndrome, cardiac arrhythmias, and significant liver injury. Patients should seek immediate medical attention if they experience symptoms like rash, swelling, difficulty breathing, chest pain or jaundice.

Kestine 10 should be avoided in individuals with known hypersensitivity to ebastine or any excipients, and caution is advised in patients with severe hepatic impairment, pregnant or nursing women unless clearly indicated, and in those taking strong CYP3A4 inhibitors without medical supervision.